122 related articles for article (PubMed ID: 3754599)
41. Aromatase enzyme catalysis is involved in the potent inhibition of estrogen biosynthesis caused by 4-acetoxy- and 4-hydroxy-4-androstene-3, 17-dione.
Covey DF; Hood WF
Mol Pharmacol; 1982 Jan; 21(1):173-80. PubMed ID: 7132956
[No Abstract] [Full Text] [Related]
42. Time-dependent inhibition of human placental aromatase with a 2,19-methyleneoxy-bridged androstenedione.
Peet NP; Burkhart JP; Wright CL; Johnston JO
J Med Chem; 1992 Aug; 35(17):3303-6. PubMed ID: 1507213
[No Abstract] [Full Text] [Related]
43. Evaluation of 6,7-aziridinyl steroids and related compounds as inhibitors of aromatase (P-450arom).
Njar VC; Grün G; Hartmann RW
J Enzyme Inhib; 1995; 9(3):195-202. PubMed ID: 8847599
[TBL] [Abstract][Full Text] [Related]
44. Additive effects of aminoglutethimide, testololactone, and 4-hydroxyandrostenedione as inhibitors of aromatase.
Santner SJ; Rosen H; Osawa Y; Santen RJ
J Steroid Biochem; 1984 Jun; 20(6A):1239-42. PubMed ID: 6748639
[TBL] [Abstract][Full Text] [Related]
45. In vitro and in vivo studies with aromatase inhibitor 4-hydroxy-androstenedione.
Brodie AM; Wing LY
Steroids; 1987; 50(1-3):89-103. PubMed ID: 3504069
[TBL] [Abstract][Full Text] [Related]
46. Thiol-containing androgens as suicide substrates of aromatase.
Bednarski PJ; Porubek DJ; Nelson SD
J Med Chem; 1985 Jun; 28(6):775-9. PubMed ID: 4009599
[TBL] [Abstract][Full Text] [Related]
47. 19-oxygenated derivatives of androst-4-ene-6,17-dione and androst-5-ene-4,17-dione as catalytic probes for the active site of aromatase.
Numazawa M; Yamada K; Kidokoro K
Biol Pharm Bull; 1999 Oct; 22(10):1134-6. PubMed ID: 10549872
[TBL] [Abstract][Full Text] [Related]
48. Aromatase inhibitors: synthesis, biological activity, and structure of 1,2-imidazolylmethylcyclopentanol derivatives.
Kato A; Ikeda Y; Sugita N; Nitta T; Enari H; Kashima A; Konno M; Niimura K
Chem Pharm Bull (Tokyo); 1995 Dec; 43(12):2152-8. PubMed ID: 8582017
[TBL] [Abstract][Full Text] [Related]
49. Ovine placental aromatase: studies of activity levels, kinetic characteristics and effects of aromatase inhibitors.
France JT; Mason JI; Magness RR; Murry BA; Rosenfeld CR
J Steroid Biochem; 1987 Aug; 28(2):155-60. PubMed ID: 3626552
[TBL] [Abstract][Full Text] [Related]
50. Inhibition of aromatase activity and of endocrine-responsive tumor growth by 10-propargylestr-4-ene-3, 17-dione and its 17-propionate derivative.
Zimniski SJ; Brandt ME; Covey DF; Puett D
Steroids; 1987; 50(1-3):135-46. PubMed ID: 3504057
[TBL] [Abstract][Full Text] [Related]
51. Aromatase inhibition by 4 beta,5 beta-epoxides of 16 alpha-hydroxyandrostenedione and its 19-oxygenated analogs, potential precursors of estriol production in the feto-placental unit.
Numazawa M; Yoshimura A; Watari Y; Matsuzaki H
Biol Pharm Bull; 2002 Dec; 25(12):1566-9. PubMed ID: 12499641
[TBL] [Abstract][Full Text] [Related]
52. Characterization of pregnant mare's serum gonadotropin-stimulated rat ovarian aromatase and its inhibition by 10-propargylestr-4-ene-3,17-dione.
Brandt ME; Puett D; Covey DF; Zimniski SJ
J Steroid Biochem; 1988 Sep; 31(3):317-24. PubMed ID: 3419162
[TBL] [Abstract][Full Text] [Related]
53. Competitive inhibition of human placental aromatase by N-n-octanoylnornicotine and other nornicotine derivatives.
Bullion K; Ohnishi S; Osawa Y
Endocr Res; 1991; 17(3-4):409-19. PubMed ID: 1811989
[TBL] [Abstract][Full Text] [Related]
54. 5 alpha-reductase activity in epithelium and stroma of prostates from intact and castrated dogs treated with androstenedione, the aromatase inhibitor 1-methyl-1,4-androstadiene-3,17-dione, and cyproterone acetate.
Tunn S; Hochstrate H; Habenicht UF; Krieg M
Prostate; 1988; 12(3):243-53. PubMed ID: 2967468
[TBL] [Abstract][Full Text] [Related]
55. 3 beta-hydroxyandrost-4-en-6-one derivatives as aromatase inhibitors.
Numazawa M; Mutsumi A; Tsuji M
Steroids; 1989 Sep; 54(3):299-311. PubMed ID: 2588304
[TBL] [Abstract][Full Text] [Related]
56. Studies on aromatase inhibition with 4-androstene-3,6,17-trione: its 3 beta-reduction and time-dependent irreversible binding to aromatase with human placental microsomes.
Numazawa M; Tsuji M; Mutsumi A
J Steroid Biochem; 1987 Sep; 28(3):337-44. PubMed ID: 3657156
[TBL] [Abstract][Full Text] [Related]
57. 10 beta-propynyl-substituted steroids. Mechanism-based enzyme-activated irreversible inhibitors of estrogen biosynthesis.
Covey DF; Hood WF; Parikh VD
J Biol Chem; 1981 Feb; 256(3):1076-9. PubMed ID: 7451489
[TBL] [Abstract][Full Text] [Related]
58. Inhibition and time-dependent inactivation of human placental aromatase by 3-oxo-17 beta-carboxamido steroids.
Greway AT; Levy MA
J Steroid Biochem; 1989 Oct; 33(4A):573-9. PubMed ID: 2811367
[TBL] [Abstract][Full Text] [Related]
59. 6-Methylenandrosta-1,4-diene-3,17-dione (FCE 24304): a new irreversible aromatase inhibitor.
Giudici D; Ornati G; Briatico G; Buzzetti F; Lombardi P; di Salle E
J Steroid Biochem; 1988; 30(1-6):391-4. PubMed ID: 3386266
[TBL] [Abstract][Full Text] [Related]
60. Synthesis and evaluation of a new series of mechanism-based aromatase inhibitors.
Lesuisse D; Gourvest JF; Hartmann C; Tric B; Benslimane O; Philibert D; Vevert JP
J Med Chem; 1992 May; 35(9):1588-97. PubMed ID: 1578485
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
